{
 "maj": "2026-09-18",
 "items": [
  {
   "id": "pmid:42748633",
   "titre": "H3K9ac promoter profiling and their association with gene expression in immune cells of T2-high asthma patients",
   "source": "Molecular immunology",
   "date": "2026-09-16",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42748633/",
   "doi": "10.1016/j.molimm.2026.09.003",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "epithelium"
  },
  {
   "id": "pmid:42742871",
   "titre": "Early Life Exposure to Air Pollutants and Childhood Asthma",
   "source": "Current allergy and asthma reports",
   "date": "2026-09-15",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42742871/",
   "doi": "10.1007/s11882-026-01293-2",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "epithelium"
  },
  {
   "id": "pmid:42696065",
   "titre": "Targeting Tight Junction Proteins to Restore Airway Epithelial Barrier Function in Asthma",
   "source": "Current allergy and asthma reports",
   "date": "2026-09-04",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42696065/",
   "doi": "10.1007/s11882-026-01290-5",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "epithelium"
  },
  {
   "id": "pmid:42734091",
   "titre": "TGF-β1 Directly Sensitizes Capsaicin-Sensitive Lung Vagal Neurons to Promote Airway Hypersensitivity",
   "source": "Acta physiologica (Oxford, England)",
   "date": "2026-10-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42734091/",
   "doi": "10.1111/apha.70311",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "nerf"
  },
  {
   "id": "pmid:42724737",
   "titre": "Gut-lung axis in chronic respiratory diseases: a narrative review of emerging insights",
   "source": "Journal of thoracic disease",
   "date": "2026-08-31",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42724737/",
   "doi": "10.21037/jtd-2026-0628",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "nerf"
  },
  {
   "id": "pmid:42705228",
   "titre": "A pulmonary innate lymphoid cell-driven serotonergic neuroimmune axis orchestrates airway hyperreactivity and cough hypersensitivity",
   "source": "Immunity",
   "date": "2026-09-07",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42705228/",
   "doi": "10.1016/j.immuni.2026.08.004",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "nerf"
  },
  {
   "id": "pmid:42699749",
   "titre": "Current perspectives on the psychological stress-immune axis in asthma: Pathophysiology, interventions, and significance for patient care",
   "source": "The World Allergy Organization journal",
   "date": "2026-08-26",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42699749/",
   "doi": "10.1016/j.waojou.2026.101453",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "nerf"
  },
  {
   "id": "pmid:42698870",
   "titre": "Pulmonary neuroendocrine cells in pediatric asthma and bronchopulmonary dysplasia: neuroimmune-developmental mechanisms and translational implications",
   "source": "Frontiers in medicine",
   "date": "2026-08-21",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42698870/",
   "doi": "10.3389/fmed.2026.1898900",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "nerf"
  },
  {
   "id": "pmid:42696560",
   "titre": "Roles of Interleukin-31 in Allergen-Driven Cough: Linking Protease-Activated Receptor-2 Activation and Vagal Ganglion Sensitization in a Dermatophagoides farinae-Induced Asthma Model",
   "source": "Brain and behavior",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42696560/",
   "doi": "10.1002/brb3.71731",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "nerf"
  },
  {
   "id": "pmid:42751698",
   "titre": "Natural medicines for asthma management: mechanisms aligned with endotypes and multi-dimensional intervention",
   "source": "Frontiers in pharmacology",
   "date": "2026-09-03",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42751698/",
   "doi": "10.3389/fphar.2026.1903220",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "remodelage"
  },
  {
   "id": "pmid:42713017",
   "titre": "Interleukin-13 R130Q aggravates airway smooth-muscle phenotypic switching and promotes airway remodeling in severe asthma",
   "source": "Frontiers in physiology",
   "date": "2026-08-25",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42713017/",
   "doi": "10.3389/fphys.2026.1906184",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "remodelage"
  },
  {
   "id": "pmid:42712896",
   "titre": "Pathogenic group 2 innate lymphoid cells as drivers of lung fibrosis in severe asthma",
   "source": "Frontiers in immunology",
   "date": "2026-08-25",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42712896/",
   "doi": "10.3389/fimmu.2026.1957593",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "remodelage"
  },
  {
   "id": "pmid:42700514",
   "titre": "Kaempferol for the treatment of asthma: A review of pre-clinical evidence on therapeutic potential and mechanism",
   "source": "International immunopharmacology",
   "date": "2026-09-05",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42700514/",
   "doi": "10.1016/j.intimp.2026.117364",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "remodelage"
  },
  {
   "id": "pmid:42698820",
   "titre": "Natural bioactive compounds targeting the macrophage clock in asthma: evidence, challenges, and perspectives",
   "source": "Frontiers in immunology",
   "date": "2026-08-21",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42698820/",
   "doi": "10.3389/fimmu.2026.1922510",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "remodelage"
  },
  {
   "id": "pmid:42751853",
   "titre": "Innovative positioning of respiratory allergen immunotherapy: a focus on precision medicine",
   "source": "Expert opinion on biological therapy",
   "date": "2026-09-17",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42751853/",
   "doi": "10.1080/14712598.2026.2716844",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "tolerance"
  },
  {
   "id": "pmid:42747714",
   "titre": "Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies",
   "source": "Current allergy and asthma reports",
   "date": "2026-09-16",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42747714/",
   "doi": "10.1007/s11882-026-01294-1",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "repositionnement"
  },
  {
   "id": "pmid:42733229",
   "titre": "Association of GLP-1-based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study",
   "source": "Expert review of respiratory medicine",
   "date": "2026-09-13",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42733229/",
   "doi": "10.1080/17476348.2026.2730537",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "repositionnement"
  },
  {
   "id": "pmid:42730051",
   "titre": "Association of Tirzepatide versus Semaglutide with Risk of Asthma Exacerbation in Patients with Asthma and Type 2 Diabetes: A US Multicenter Retrospective Cohort Study",
   "source": "Journal of asthma and allergy",
   "date": "2026-09-07",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42730051/",
   "doi": "10.2147/JAA.S637738",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "repositionnement"
  },
  {
   "id": "pmid:42712413",
   "titre": "Tirzepatide and the risk of asthma exacerbations in patients with type 2 diabetes",
   "source": "Frontiers in endocrinology",
   "date": "2026-08-25",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42712413/",
   "doi": "10.3389/fendo.2026.1928877",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "repositionnement"
  },
  {
   "id": "pmid:42744207",
   "titre": "Identification of modifiable risk factors to prevent atopic wheeze in infants born to mothers with asthma: a cohort study",
   "source": "Respiratory medicine",
   "date": "2026-09-15",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42744207/",
   "doi": "10.1016/j.rmed.2026.109154",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "prevention"
  },
  {
   "id": "pmid:42753985",
   "titre": "Reframing the asthma microbiome: Multikingdom, multisite, and multiomic perspectives",
   "source": "The Journal of allergy and clinical immunology",
   "date": "2026-09-17",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42753985/",
   "doi": "10.1016/j.jaci.2026.08.026",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "microbiome"
  },
  {
   "id": "pmid:42751907",
   "titre": "[Research progress on the microbiota-immune-metabolism axis in childhood obesity-related asthma]",
   "source": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics",
   "date": "2026-01-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42751907/",
   "doi": "10.7499/j.issn.1008-8830.2601132",
   "type": "article",
   "types": [
    "Journal Article",
    "Review",
    "English Abstract"
   ],
   "voie": "microbiome"
  },
  {
   "id": "pmid:42751182",
   "titre": "Childhood asthma and the microbiome: from gut-lung axis mechanisms to precision prevention strategies",
   "source": "Frontiers in immunology",
   "date": "2026-09-02",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42751182/",
   "doi": "10.3389/fimmu.2026.1902053",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "microbiome"
  },
  {
   "id": "pmid:42750356",
   "titre": "Lactiplantibacillus Plantarum GUANKE Alleviates Allergic Asthma by Restricting Monocyte-to-DC Differentiation Via Microbiota-Associated IAA",
   "source": "Advanced science (Weinheim, Baden-Wurttemberg, Germany)",
   "date": "2026-09-16",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42750356/",
   "doi": "10.1002/advs.202523466",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "microbiome"
  },
  {
   "id": "pmid:42725673",
   "titre": "Gut Microbiota Mediates the Protective Effect of Saposhnikovia divaricata Polysaccharides against Ovalbumin-induced Allergic Asthma",
   "source": "Journal of physiological investigation",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42725673/",
   "doi": "10.4103/ejpi.EJPI-D-25-00080",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "microbiome"
  },
  {
   "id": "pmid:42724464",
   "titre": "Probiotics in asthma: immunoregulatory mechanisms and emerging opportunities for respiratory delivery-a narrative review",
   "source": "Translational pediatrics",
   "date": "2026-08-31",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42724464/",
   "doi": "10.21037/tp-2026-0390",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "microbiome"
  },
  {
   "id": "pmid:42754089",
   "titre": "Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3",
   "source": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology",
   "date": "2026-09-17",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42754089/",
   "doi": "10.1016/j.anai.2026.09.737",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42753984",
   "titre": "The Staphylococcus aureus serine protease-like protein B is a potent allergen in a murine asthma model",
   "source": "The Journal of allergy and clinical immunology",
   "date": "2026-09-17",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42753984/",
   "doi": "10.1016/j.jaci.2026.08.025",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42753515",
   "titre": "Computational identification of candidate ST2-binding bioactive compounds as putative modulators for severe type 2-high asthma",
   "source": "Computational biology and chemistry",
   "date": "2026-09-13",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42753515/",
   "doi": "10.1016/j.compbiolchem.2026.109352",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42751837",
   "titre": "[How I treat… severe «T2-high» asthma]",
   "source": "Revue medicale de Liege",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42751837/",
   "doi": "",
   "type": "article",
   "types": [
    "Journal Article",
    "Review",
    "English Abstract",
    "Practice Guideline"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42748074",
   "titre": "Pediatric spontaneous-reporting patterns for biologics approved or used for asthma: Analysis of the FDA adverse event reporting system",
   "source": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42748074/",
   "doi": "10.1111/pai.70495",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42727290",
   "titre": "Evolution of the level of eosinophilic asthma in asthmatic children over time",
   "source": "Respiratory medicine and research",
   "date": "2026-08-27",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42727290/",
   "doi": "10.1016/j.resmer.2026.101321",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42715838",
   "titre": "Metabolic-epigenetic reprogramming of airway fibroblasts by K + N therapy suppresses IL-33 and ameliorates allergic asthma",
   "source": "International immunopharmacology",
   "date": "2026-09-09",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42715838/",
   "doi": "10.1016/j.intimp.2026.117386",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42714006",
   "titre": "Biologic Therapy for Severe Asthma: Biomarker-Guided Precision Treatment and Immunopathological Mechanisms",
   "source": "Journal of visualized experiments : JoVE",
   "date": "2026-09-08",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42714006/",
   "doi": "10.3791/71404",
   "type": "article",
   "types": [
    "Journal Article",
    "Video-Audio Media",
    "Review"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42707785",
   "titre": "Non-type 2 airway inflammation in severe asthma: from bench to bedside",
   "source": "Frontiers in immunology",
   "date": "2026-08-24",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42707785/",
   "doi": "10.3389/fimmu.2026.1930520",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42705813",
   "titre": "An Unanchored Matching-Adjusted Indirect Comparison of Dupilumab and Tezepelumab in Asthma Has Several Limitations",
   "source": "The journal of allergy and clinical immunology. In practice",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42705813/",
   "doi": "10.1016/j.jaip.2026.07.013",
   "type": "article",
   "types": [
    "Letter"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42704053",
   "titre": "Immunologic Effects of Tezepelumab in Rhinovirus-Triggered Near-Fatal Asthma",
   "source": "Journal of investigational allergology & clinical immunology",
   "date": "2026-09-07",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42704053/",
   "doi": "10.18176/jiaci.1204",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42694611",
   "titre": "Mitochondrial reprogramming of neutrophil extracellular traps in chronic obstructive pulmonary disease and asthma: toward a phenotype-driven therapeutic framework",
   "source": "Frontiers in immunology",
   "date": "2026-08-20",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42694611/",
   "doi": "10.3389/fimmu.2026.1920684",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "alarmines"
  },
  {
   "id": "pmid:42754292",
   "titre": "Bridging the gap between clinical outcomes and patient experiences in asthma: a targeted review of exacerbation, control, and remission outcomes",
   "source": "The Journal of asthma : official journal of the Association for the Care of Asthma",
   "date": "2026-09-17",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42754292/",
   "doi": "10.1080/02770903.2026.2734974",
   "type": "article",
   "types": [
    "Journal Article",
    "Review"
   ],
   "voie": "remission"
  },
  {
   "id": "pmid:42749226",
   "titre": "Structural remission in severe asthma: distinguishing modifiable remodeling from structural sequelae",
   "source": "Respiratory medicine",
   "date": "2026-09-16",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42749226/",
   "doi": "10.1016/j.rmed.2026.109162",
   "type": "article",
   "types": [
    "Letter"
   ],
   "voie": "remission"
  },
  {
   "id": "pmid:42741602",
   "titre": "Achieving clinical remission in moderate-to-severe asthma using inhaled triple therapy",
   "source": "ERJ open research",
   "date": "2026-09-14",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42741602/",
   "doi": "10.1183/23120541.00054-2026",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "remission"
  },
  {
   "id": "pmid:42716466",
   "titre": "Assessing the impact of earlier initiation of biologics on clinical remission and other outcomes in a global real-life severe asthma cohort from CHRONICLE, ISAR and OPCRD",
   "source": "Chest",
   "date": "2026-09-09",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42716466/",
   "doi": "10.1016/j.chest.2026.06.076",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "remission"
  },
  {
   "id": "pmid:42748054",
   "titre": "A circulating odd-chain fatty acid biomarker signature discriminates pediatric allergic rhinitis with asthma from related allergic airway phenotypes",
   "source": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42748054/",
   "doi": "10.1111/pai.70483",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "ia"
  },
  {
   "id": "pmid:42731116",
   "titre": "CCR2/CCR5 Signaling Defines a Pathogenic Interstitial Macrophage Subset That Drives Severe Asthma",
   "source": "Clinical and translational allergy",
   "date": "2026-09-01",
   "url": "https://pubmed.ncbi.nlm.nih.gov/42731116/",
   "doi": "10.1002/clt2.70201",
   "type": "article",
   "types": [
    "Journal Article"
   ],
   "voie": "ia"
  },
  {
   "id": "doi:10.64898/2026.08.31.26361659",
   "titre": "Body mass index trajectories from birth to adolescence and their association with asthma: a longitudinal study of the Leicester Respiratory Cohorts",
   "source": "medrxiv (prépublication)",
   "date": "2026-09-04",
   "url": "https://doi.org/10.64898/2026.08.31.26361659",
   "doi": "10.64898/2026.08.31.26361659",
   "type": "preprint",
   "abstract": "INTRODUCTIONAsthma has been associated with obesity in both adults and children. We investigated the association between longitudinal BMI trajectories and asthma at ages 8-9, 12-13, and 16-17 years in a UK cohort of White and South Asian children and adolescents.\n\nMETHODSWe analysed data from the Leicester Respiratory Cohorts, population-based cohort studies that recruited 0-4-year-old children in 1990 (N = 1650) and 1998 (N = 8700) and followed them up until 2010. Outcome data on asthma came from postal questionnaires throughout infancy, childhood, and adolescence. BMI data came from birth re",
   "voie": "autres"
  },
  {
   "id": "doi:10.64898/2026.09.04.26362226",
   "titre": "Adaptive Multimodal Fusion in Radiology: Dynamic Balancing of Visual Findings and Clinical Context",
   "source": "medrxiv (prépublication)",
   "date": "2026-09-07",
   "url": "https://doi.org/10.64898/2026.09.04.26362226",
   "doi": "10.64898/2026.09.04.26362226",
   "type": "preprint",
   "abstract": "The automatic detection of thoracic pathologies remains a challenge when the visual evidence present in the chest X-ray (CXR) is subtle, ambiguous, or practically imperceptible, and the available textual information is limited, especially in the early phases of patient care. To address this limitation, in this work a clinically motivated subset of MIMIC-CXR is taken as the study set, composed of four diseases associated with dyspnea presentations in the emergency department (heart failure, pulmonary infection, COPD/asthma, and pulmonary embolism), along with a control class. This selection all",
   "voie": "autres"
  },
  {
   "id": "doi:10.64898/2026.09.03.26362165",
   "titre": "Rethinking Input Complexity in Transformer-Based Clinical Prediction: Implications for Feature Dimensionality and Sequence Length in Longitudinal EHR Data",
   "source": "medrxiv (prépublication)",
   "date": "2026-09-07",
   "url": "https://doi.org/10.64898/2026.09.03.26362165",
   "doi": "10.64898/2026.09.03.26362165",
   "type": "preprint",
   "abstract": "ObjectiveTransformer-based models for clinical prediction using longitudinal electronic health record (EHR) data are often developed with large feature sets and long patient histories under the assumption that more data improves performance. However, high-dimensional inputs and long sequences increase computational burden, potentially limiting scalability. We evaluated how feature dimensionality and sequence length affect predictive performance, calibration, risk stratification, and computational efficiency in EHR prediction.\n\nMethodsUsing longitudinal EHR data from adults with mild asthma in ",
   "voie": "autres"
  },
  {
   "id": "doi:10.64898/2026.09.14.26363037",
   "titre": "Nasal transcriptomics characterize T-helper (T)2-low asthma endotypes in a study of Puerto Rican and Dominican adults living in the U.S.",
   "source": "medrxiv (prépublication)",
   "date": "2026-09-15",
   "url": "https://doi.org/10.64898/2026.09.14.26363037",
   "doi": "10.64898/2026.09.14.26363037",
   "type": "preprint",
   "abstract": "IMPORTANCECD4+ T helper (T) 1, T2 and T17 cells have helped identify asthma endotypes in predominantly non-Hispanic White adults. Identifying asthma endotypes in diverse subgroups should help develop personalized medicine in asthma.\n\nOBJECTIVETo characterize asthma endotypes and their association with selected variables and asthma severity/control in adults.\n\nDESIGN, SETTING, AND PARTICIPANTSCross-sectional and longitudinal analyses of nasal samples from the SOL-Asthma study of Puerto Rican and Dominican adults with (cases, n=313) and without (controls, n=371) asthma in the Bronx (NY) and Chic",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07635537",
   "titre": "Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-18",
   "url": "https://clinicaltrials.gov/study/NCT07635537",
   "type": "essai",
   "pays": [
    "Spain"
   ],
   "intervention": "RESPiraIA-Asma",
   "statut": "NOT_YET_RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07828327",
   "titre": "Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-18",
   "url": "https://clinicaltrials.gov/study/NCT07828327",
   "type": "essai",
   "pays": [
    "China"
   ],
   "intervention": "Depemokimab",
   "statut": "NOT_YET_RECRUITING",
   "voie": "alarmines"
  },
  {
   "id": "nct:NCT07137923",
   "titre": "SMART Implementation-Effectiveness Trial 1",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-18",
   "url": "https://clinicaltrials.gov/study/NCT07137923",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "Clinical decision support + education (CDS+), Control",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07138027",
   "titre": "SMART Implementation-Effectiveness Trial 2",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-18",
   "url": "https://clinicaltrials.gov/study/NCT07138027",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "Clinical decision support + education (CDS+) and population health management (PHM), Control",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07738016",
   "titre": "Artificially Intelligent Robot Control",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-16",
   "url": "https://clinicaltrials.gov/study/NCT07738016",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "Artificially Intelligent Robot (AIR) Control Intervention, Standard Asthma Education",
   "statut": "NOT_YET_RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07709754",
   "titre": "PULmonary Stimulation for Asthma Relief",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-16",
   "url": "https://clinicaltrials.gov/study/NCT07709754",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "Spinal Cord Stimulation",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07819747",
   "titre": "Resources and Education for Addressing Chronic Health (REACH)",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-15",
   "url": "https://clinicaltrials.gov/study/NCT07819747",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "REACH",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT06823622",
   "titre": "Digital Delivery of Person-centered Transitional Care",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-15",
   "url": "https://clinicaltrials.gov/study/NCT06823622",
   "type": "essai",
   "pays": [
    "Sweden"
   ],
   "intervention": "Stepstones transition program",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07396987",
   "titre": "Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-14",
   "url": "https://clinicaltrials.gov/study/NCT07396987",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "ER-Initiated Telehealth Referral",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07504926",
   "titre": "A Randomised Feasibility Study of CPAP in Large Airway Collapse",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-14",
   "url": "https://clinicaltrials.gov/study/NCT07504926",
   "type": "essai",
   "pays": [
    "United Kingdom"
   ],
   "intervention": "CPAP",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07816718",
   "titre": "Sustained Asthma Remission and Reduced RElapse Using a COmprehensive Management Strategy Randomized Control Trial",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-14",
   "url": "https://clinicaltrials.gov/study/NCT07816718",
   "type": "essai",
   "pays": [
    "Canada"
   ],
   "intervention": "Comprehensive Biomarker-Guided Management Strategy, Standard of Care",
   "statut": "NOT_YET_RECRUITING",
   "voie": "remission"
  },
  {
   "id": "nct:NCT07516184",
   "titre": "Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-14",
   "url": "https://clinicaltrials.gov/study/NCT07516184",
   "type": "essai",
   "pays": [
    "China"
   ],
   "intervention": "Pulmonary function Test intervention",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT06023589",
   "titre": "A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-11",
   "url": "https://clinicaltrials.gov/study/NCT06023589",
   "type": "essai",
   "pays": [
    "Argentina",
    "Brazil",
    "Canada",
    "China",
    "Colombia",
    "France",
    "Hungary",
    "Italy",
    "Japan",
    "Mexico",
    "Netherlands",
    "Philippines",
    "Poland",
    "Romania",
    "South Africa",
    "South Korea",
    "Spain",
    "Thailand",
    "Turkey (Türkiye)",
    "Ukraine",
    "United Kingdom",
    "United States"
   ],
   "intervention": "Tezepelumab, Placebo",
   "statut": "RECRUITING",
   "voie": "alarmines"
  },
  {
   "id": "nct:NCT05734261",
   "titre": "Forced Oscillations Technique During a Metacholine Test in Children",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-11",
   "url": "https://clinicaltrials.gov/study/NCT05734261",
   "type": "essai",
   "pays": [
    "France"
   ],
   "intervention": "Airway Oscillation System",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07815730",
   "titre": "Development and Validation of the Indian Asthma Care Bundle for Reducing Readmission and Improving Post-hospitalisation Care After Discharge From Hospital Due to an Acute Asthma Exacerbation",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-11",
   "url": "https://clinicaltrials.gov/study/NCT07815730",
   "type": "essai",
   "pays": [
    "India"
   ],
   "intervention": "Indian Asthma Care Bundle (I-ACB)",
   "statut": "NOT_YET_RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT05776927",
   "titre": "A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-11",
   "url": "https://clinicaltrials.gov/study/NCT05776927",
   "type": "essai",
   "pays": [
    "France",
    "Hungary",
    "Poland",
    "Romania",
    "Slovakia",
    "South Africa",
    "Spain",
    "Taiwan"
   ],
   "intervention": "QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07732023",
   "titre": "A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma",
   "source": "ClinicalTrials.gov · PHASE1",
   "date": "2026-09-10",
   "url": "https://clinicaltrials.gov/study/NCT07732023",
   "type": "essai",
   "pays": [
    "China"
   ],
   "intervention": "SKB575, Placebo",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07241117",
   "titre": "CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma",
   "source": "ClinicalTrials.gov · PHASE4",
   "date": "2026-09-10",
   "url": "https://clinicaltrials.gov/study/NCT07241117",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "Implementation bundle",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07403487",
   "titre": "Phase II Trial of RC1416 Injection in Asthma",
   "source": "ClinicalTrials.gov · PHASE2",
   "date": "2026-09-10",
   "url": "https://clinicaltrials.gov/study/NCT07403487",
   "type": "essai",
   "pays": [
    "China"
   ],
   "intervention": "RC1416, RC1416 Placebo",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07488897",
   "titre": "RIG 101 Trial in Healthy Adults and Adults With Asthma",
   "source": "ClinicalTrials.gov · PHASE1, PHASE2",
   "date": "2026-09-09",
   "url": "https://clinicaltrials.gov/study/NCT07488897",
   "type": "essai",
   "pays": [
    "United Kingdom"
   ],
   "intervention": "RIG-101, Placebo",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT06471257",
   "titre": "A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-09",
   "url": "https://clinicaltrials.gov/study/NCT06471257",
   "type": "essai",
   "pays": [
    "China",
    "Hong Kong"
   ],
   "intervention": "Budesonide/Albuterol metered dose inhaler, MDI, Albuterol sulfate metered dose inhaler, MDI",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT05757102",
   "titre": "A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-09",
   "url": "https://clinicaltrials.gov/study/NCT05757102",
   "type": "essai",
   "pays": [
    "Argentina",
    "Australia",
    "Chile",
    "Israel",
    "Mexico",
    "New Zealand",
    "South Korea",
    "Turkey (Türkiye)",
    "United States"
   ],
   "intervention": "FF/UMEC/VI, ELLIPTA, FF/VI",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT06935084",
   "titre": "ASTHMAXcel Voice Study",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-08",
   "url": "https://clinicaltrials.gov/study/NCT06935084",
   "type": "essai",
   "pays": [
    "United States"
   ],
   "intervention": "ASTHMAXcel Voice platform",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07276724",
   "titre": "A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-08",
   "url": "https://clinicaltrials.gov/study/NCT07276724",
   "type": "essai",
   "pays": [
    "Bulgaria",
    "Czechia",
    "Germany",
    "Greece",
    "Hungary",
    "Latvia",
    "Netherlands",
    "Portugal",
    "Romania",
    "South Africa",
    "United States"
   ],
   "intervention": "GB-0895, Placebo",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07359846",
   "titre": "A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-08",
   "url": "https://clinicaltrials.gov/study/NCT07359846",
   "type": "essai",
   "pays": [
    "Argentina",
    "Australia",
    "Belgium",
    "Estonia",
    "France",
    "Italy",
    "Japan",
    "Serbia",
    "Slovakia",
    "Spain",
    "Turkey (Türkiye)",
    "Ukraine",
    "United Kingdom",
    "United States"
   ],
   "intervention": "GB-0895, Placebo",
   "statut": "RECRUITING",
   "voie": "autres"
  },
  {
   "id": "nct:NCT07309614",
   "titre": "A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma",
   "source": "ClinicalTrials.gov · PHASE3",
   "date": "2026-09-04",
   "url": "https://clinicaltrials.gov/study/NCT07309614",
   "type": "essai",
   "pays": [
    "Australia",
    "Canada",
    "United Kingdom"
   ],
   "intervention": "Dupilumab Prefilled Syringe, Placebo Injection",
   "statut": "RECRUITING",
   "voie": "remission"
  },
  {
   "id": "nct:NCT05999032",
   "titre": "The Puerto Rico Asthma Integrated Response Program (\"PR-AIR\")",
   "source": "ClinicalTrials.gov · NA",
   "date": "2026-09-04",
   "url": "https://clinicaltrials.gov/study/NCT05999032",
   "type": "essai",
   "pays": [
    "Puerto Rico",
    "United States"
   ],
   "intervention": "CASE in person version (High Intensity Package), CASE-V remote version (Low Intensity Package), CASE and HARP in person (High Intensity package)",
   "statut": "RECRUITING",
   "voie": "autres"
  }
 ],
 "nouveaux": []
}